Marie Stopes International
Phnom Penh, Cambodia
NCT Number: NCT01823861
An individual randomised controlled trial (RCT) to evaluate the effectiveness of a voice-based mobile phone health (mHealth) intervention to support post-abortion family planning (PAFP) at four Marie Stopes International clinics in Cambodia.
The study seeks to address the research question: does a PAFP mHealth intervention increase use of contraception in Cambodia? STUDY RESULTS: http://www.who.int/bulletin/online_first/en/
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Phnom Penh, Cambodia
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Automated voice message to support post-abortion contraception use every two weeks for total of three months. Direct follow up phone call by family planning counsellor depending on response to voice message.
Time frame: 4 months
Self-reported use of pill, coil, implant or injection for all participants. Objective measurement of contraceptive use for participants from one clinic.
Time frame: 4 months
Time frame: 4 months
Time frame: 4 months
Looking for future studies?
Notify MeMarie Stopes International
Other
Acronym: MOTIF
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05139121
Contraception
Mobile, Alabama, United States
View Trial DetailsNCT03067272
Contraception
New York, United States
View Trial DetailsNCT06664034
Cancer, Contraception
Brawley, California, United States
View Trial DetailsNCT05818254
Autoimmune Diseases, Connective Tissue Diseases
Chicago, Illinois, United States
View Trial Details